Literature DB >> 2873165

In vitro antioxidant properties of potential biotransformation products of salicylate, sulphasalazine and amidopyrine.

W H Betts, M W Whitehouse, L G Cleland, B Vernon-Roberts.   

Abstract

2,3-and 2,5-dihydroxybenzoate (formed from salicylate by nonenzymatic or enzymatic hydroxylation), and 5-aminosalicylate (a prime metabolite of sulphasalazine) are highly efficient quenchers of the chemiluminescence (CL) produced by an oxy radical flux. Monohydric phenols (including salicylate) and meta-dihydric phenols are virtually inactive. These findings suggest that the para- or ortho-configuration of hydroxy/amino groups is important for this activity. These differences in activity between 2,3- and 2,5-dihydroxybenzoate, 5-aminosalicylate and monohydric phenols/2,4-, 2,6-dihydroxybenzoate were not seen in assays monitoring hydroxyl radicals. 4-aminophenazone (an oxidation product of both amidopyrine/aminopyrine and isopyrine), 4-hydroxyphenazone and some dietary catechols (and ascorbate), are also quenchers of oxy radical-associated CL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2873165     DOI: 10.1016/0748-5514(85)90131-x

Source DB:  PubMed          Journal:  J Free Radic Biol Med        ISSN: 0748-5514


  10 in total

1.  Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA.

Authors:  K D Rainsford; D R Haynes
Journal:  Inflammopharmacology       Date:  2013-07-04       Impact factor: 4.473

Review 2.  Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation.

Authors:  T Yamada; M B Grisham
Journal:  Klin Wochenschr       Date:  1991-12-15

Review 3.  Wine as a biological fluid: history, production, and role in disease prevention.

Authors:  G J Soleas; E P Diamandis; D M Goldberg
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.

Authors:  Preet K Dhillon; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2011-02-26       Impact factor: 7.396

5.  Aspirin resistance: Fact or fiction? A point of view.

Authors:  Jawahar L Mehta; Bhavna Mohandas
Journal:  World J Cardiol       Date:  2010-09-26

Review 6.  Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.

Authors:  Matthias Hermann; Frank Enseleit; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

7.  Is local biotransformation the key to understanding the pharmacological activity of salicylates and gold drugs?

Authors:  M W Whitehouse; G G Graham
Journal:  Inflamm Res       Date:  1996-12       Impact factor: 4.575

Review 8.  Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.

Authors:  Michael Whitehouse; Desley Butters; Barrie Vernon-Roberts
Journal:  Inflammopharmacology       Date:  2013-05-19       Impact factor: 4.473

9.  Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects.

Authors:  M B Grisham; K Ware; S Marshall; T Yamada; I S Sandhu
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

10.  Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase.

Authors:  D J de Jong; E M J van der Logt; A van Schaik; H M J Roelofs; W H M Peters; T H J Naber
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.